Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops and sells pharmaceuticals and medical devices

Photocure ASA engages as a pharmaceutical company, which engages in the provision of photodynamic diagnosis and treatment.

It operates through Commercial Franchise and Development Portfolio segments.

The Commercial Franchise segment includes Hexvix/Cysview products and is broken down into own and partner sales.

The Development Portfolio segment offers development of commercial products and pipeline
products.

The company was founded on August 27, 1993 and is headquartered in Oslo, Norway.

Number of employees : 49 persons.
Sales per Businesses
20142015Delta
NOK (in Million)%NOK (in Million)%
Cancer92.0171.4%---
Dermatology1.571.2%---
Commercial Franchise--134.72100%-
Sales per Regions
20142015Delta
NOK (in Million)%NOK (in Million)%
Partner Countries Europe47.8937.1%60.6545% +26.63%
Nordic Countries33.4225.9%38.6728.7% +15.72%
United States12.289.5%23.0217.1% +87.47%
Managers
NameAgeSinceTitle
Kjetil Hestdal MD, PhD561997President, Chief Executive Officer & Media Contact
Bente-Lill Bjerkelund Romøren672014Chairman
Erik Dahl-2012Chief Financial Officer & IR Contact
Inger Ferner Heglund612006Vice President-Research & Development
Xavier Denis Yon762011Independent Director
Synne Hermansen Røine, MBA372014Independent Director
Tom Edward Pike56-Independent Director
Lars Rønn52-Independent Director
Grete Hogstad602005Vice President-Strategic Marketing
Gry Stensrud, PhD462006VP-Technical Development & Operations
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 21,545,429 15,878,472 73.7% 809 0.0% 73.7%
Shareholders
NameEquities%
Alexander Brask Hansson 3,230,000 15.0%
KLP Kapitalforvaltning AS 1,414,043 6.56%
Fondsfinans Kapitalforvaltning ASA 1,175,550 5.46%
Hunter Hall Investment Management Ltd. 863,782 4.01%
Danske Capital AS 859,851 3.99%
MP Pensjon PK 850,000 3.95%
Skagen AS 452,000 2.10%
Eika Kapitalforvaltning AS 391,799 1.82%
DNB Asset Management AS 336,020 1.56%
Polar Capital LLP 254,549 1.18%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
PHOTOCURE ASA14.56%119
JOHNSON & JOHNSON8.05%301 952
ROCHE HOLDING LTD.-19.97%189 184
PFIZER INC.-3.38%187 755
NOVARTIS AG-20.79%178 671
MERCK & CO., INC.13.82%165 759
SANOFI-4.45%102 757
BRISTOL-MYERS SQUIBB C..-19.71%92 302
GLAXOSMITHKLINE PLC6.52%89 608
BAYER AG-24.74%81 779
ELI LILLY AND CO-20.26%74 174
ALLERGAN PLC-39.69%70 691
NOVO NORDISK A/S-39.23%70 014
ASTRAZENECA PLC-12.54%65 712
ABBOTT LABORATORIES-13.87%56 949
SHIRE PLC-7.82%49 405
TAKEDA PHARMACEUTICAL ..-21.73%31 583
ASTELLAS PHARMA INC-10.77%28 716
MYLAN NV-36.19%19 296
EISAI CO., LTD-13.04%16 254
JIANGSU HENGRUI MEDICI..-80.53%16 083
Sector Pharmaceuticals - NEC
Photocure ASA : Connections
Photocure ASA
Hoffsveien 4
Oslo 0275

Phone : +47.22.06.22.10
Fax : +47.22.06.22.18
Web : www.photocure.com
© 2016 People , Fundamentals and Ownership